Maxime Danilo

Maxime Danilo is currently the Head of Late Process Development & Analytics at CHUV (Centre hospitalier universitaire vaudois), where they lead a team focused on transitioning cellular therapies from research to clinical trials, ensuring compliance with Good Manufacturing Practice (GMP). Previously, Maxime held roles at CHUV as a Deputy Head and Process Development Scientist, as well as a Scientist in process development. Their academic background includes a PhD in Immunology from the University of Lausanne and a Master of Engineering from Polytech'Clermont-Ferrand, complemented by extensive experience in cellular assays and molecular biology from various internships and research positions. Maxime's dedication to patient safety and product efficacy remains at the forefront of their professional endeavors.